Advertisement
News
Subscribe to Surgical Products Magazine News
View Sample

FREE Email Newsletter

Surgical Products Daily

Study: Hip Replacement Market Recovering

August 5, 2014 11:01 am | Comments

The hip replacement market is beginning to recover from the global recession and controversies surrounding metal-on-metal implants, with procedure volumes growing and patient confidence at an all-time high. According to GlobalData, approximately 1.7 million hip replacement procedures, including partial, primary, revision and resurfacing, were performed across the globe in 2013, and this figure is expected to increase to 2.5 million by 2020.

Stem Cell Scientist in Research Scandal Found Dead

August 5, 2014 10:48 am | Comments

Yoshiki Sasai, a senior Japanese scientist embroiled in a stem-cell research scandal died Tuesday in an apparent suicide, police said. Sasai, who supervised and co-authored stem-cell research papers that had to be retracted due to falsified contents, was found suffering from cardiac arrest at the government-affiliated science institute RIKEN in Kobe, in western Japan, according to Hyogo prefectural police.

Study provides look at future of transcranial ultrasound therapy

August 4, 2014 11:22 am | Comments

Research is taking place in transcranial ultrasound therapy, which in the future can potentially be applied to the treatment of brain tumours and targeted drug delivery. The therapy modality has already been successfully applied to the treatment of neuropathic pain disorder and essential tremors. The study focuses on two issues: skull-base heating and formation of standing-waves.

Advertisement

Once-conjoined twins celebrate 10 years of separation

August 4, 2014 10:24 am | Comments

The delicate separation 10 years ago of conjoined twins from the Philippines wasn't perfect, but the boys' mother says their very survival is reason enough to celebrate the anniversary. The boys were separated on Aug. 4, 2004, in an operation that climaxed a then-unusual "staged separation" that took four surgeries over nine months.

Group Finds Excellent Clinical Results and Expanded Enrollment in OCCLUDE I Study

July 31, 2014 4:19 pm | Comments

ArtVentive Medical Group announced excellent clinical results in conjunction with expanded enrollment in the ArtVentive Endoluminal Occlusion System, OCCLUDE I post-market surveillance study. In conjunction with the study, four female patients were treated for pelvic congestion syndrome and seven male patients were treated for varicoceles using the ArtVentive EOS™ device.

Kala Pharmaceuticals Initiates Phase 2 Trial

July 31, 2014 3:57 pm | Comments

“We are excited about the progress of our lead nanotechnology-based program, LE-MPP, with four active clinical trials,” said Kim Brazzell, Ph.D., Chief Medical Officer of Kala. “With the initiation of our latest trial in RVO and DME, Kala is making significant progress toward demonstrating the unique ability of Kala’s MPP platform to deliver drugs to the back of the eye following topical administration.”

BioTime Expands Clinical Development Of Bladder Cancer Diagnostic

July 31, 2014 3:40 pm | Comments

BioTime, Inc. (NYSE MKT: BTX) and its subsidiary OncoCyte Corporation announced that OncoCyte has expanded the clinical development of its urine-based bladder cancer diagnostic test by initiating a multi-site clinical trial. OncoCyte’s initial clinical study of its bladder cancer diagnostic test began in January and involves pathology specimens being collected at a leading medical institution with a reputation for excellence and discovery.

American CareSource Secures $5 Million Line of Credit

July 31, 2014 3:13 pm | Comments

American CareSource Holdings a leading national network of ancillary health care providers and operator of urgent care centers, has closed on a $5 million line of credit with a top-tier U.S. bank, giving the it funding to continue its strategy of acquiring urgent care centers. “The credit facility offers us financial flexibility at a very attractive interest rate," said Dr. Richard W. Turner, Chairman of the Board and CEO.

Advertisement

Women Could Benefit From Tamoxifen Therapy For Breast Cancer

July 31, 2014 2:00 pm | Comments

Innovative research has identified a gene signature that has potential to identify which patients will benefit from tamoxifen therapy. Tamoxifen is an endocrine therapy that is one of the most frequently used medications worldwide to treat breast cancer after surgery. However, even among those patients for whom tamoxifen is effective at reducing recurrence risk, many of them experience menopausal-like side effects.

Active O Kicks Off New Clinical Trial Studying Non-Surgical Treatment For Lower Back Pain

July 31, 2014 1:47 pm | Comments

A clinical trial being conducted at several high-profile centers in Canada has begun recruiting patients to investigate a new, non-surgical treatment for lower back pain caused by a contained herniated disc. The trial is studying a minimally invasive injection of natural gases designed to dissolve a small amount of disc tissue in order to resolve the disc herniation.

Eighty Percent Of Aortic Stenosis Patients Report Same/Better Health 1 Year After Treatment

July 31, 2014 1:01 pm | Comments

A survey of 13,860 patients who had undergone interventions for aortic valve disease has revealed that over 80 percent were in the same or a better state of health one year after the intervention. Aortic stenosis is the most frequent valvular heart disease in the aging Western population, and the prognosis of this disease in symptomatic patients with conservative therapy is poor.

Report: Cosmetic Eyelid Surgery Provides Significant Relief From Migraines

July 31, 2014 12:37 pm | Comments

Dr. Oren Tessler, Assistant Professor of Clinical Surgery at Lousiana State University, is part of a team of plastic and reconstructive surgeons who report a high success rate using a method to screen and select patients for a specific surgical migraine treatment technique. More than 90% of the patients who underwent this surgery to decompress the nerves that trigger migraines experienced relief and also got a bonus cosmetic eyelid surgery.

Vacuum Treatment May Limit Damage From Traumatic Brain Injury

July 31, 2014 11:16 am | Comments

Controlled application of vacuum pressure is a promising approach to limiting tissue damage after traumatic brain injury (TBI). In the study, which was funded by a major grant from the U.S. Army, the researchers tested the mechanical tissue resuscitation approach by inducing localized TBI in swine, then applying negative pressure—that is, a mild vacuum—over the injured area of the brain.

CrowdOptic's Google Glass Broadcasting Solution Aims To Improve Surgeon Training

July 30, 2014 11:28 am | Comments

CrowdOptic, a maker of mobile and wearable broadcasting solutions, announced its working with the Department of Cardiothoracic Surgery at Stanford University Medical Center to help improve resident training in complex surgical procedures, through the use of Google Glass technology. CrowdOptic's software lets one Google Glass wearer inherit another's point of view, simply by looking in the other user's direction.

Generation Of Tanners See Spike In Deadly Melanoma

July 30, 2014 11:11 am | Comments

A report released Tuesday by the acting U.S. surgeon general cited an alarming 200 percent jump in deadly melanoma cases since 1973. The report blames a generation of sun worshipping for the $8 billion spent to treat all forms of skin cancer each year.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading